...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Carve-Outs - revised
2
Dec 20, 2015 10:44AM

The article that F6 posted said:

"In an equity carveout, the parent company sells a stake in the subsidiary company (usually 20% or less) for cash proceeds in an IPO and often distributes the remaining interest to existing shareholders at a later date. Unlike a traditional spin-off, an equity carveout generates capital since shares in the subsidiary are sold to the public via an IPO."

So I probably should have said that ZLtd could sell up to 20% of ZLtd which could amount to 6,880,000 shares @ say $5.00/share = $34.4 million (coincidence?). But would they distribute the entire 34.4 million to the current 105 million Zen shareholders...or just the equvalenet % (i.e. 20% in this example) which would be = $6.88 million or .065/share?? And we would still have our ZCC shares which include any remaining ZLtd ownership.

I just thought it would be nice to add to the confusion...lol. At least now anyone who is able to attend the meeting can hopefully get all the answers we don't have here.

Whether it's spinouts or carve-outs, it's all good imo. As I said, we can all fill up on appetizers.

GLTA

PVLee


4
Dec 20, 2015 01:17PM
Share
New Message
Please login to post a reply